Lupin recalls nearly 3,000 bottles of OCD medication in the US after subpar stability testing results
Mumbai's Lupin has issued a voluntary recall of 2,724 bottles of the tricyclic antidepressant clomiPRAMINE hydrochloride, which is used to treat obsessive-compulsive disorder. Lupin’s product pull covers 25-mg capsules of the drug in 100-count bottles.
